News Conference News ESC 2025 ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD L.A. McKeown September 09, 2025
News Conference News ESC 2023 ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More Michael O'Riordan September 06, 2023
News Conference News ESC 2022 Less Death, Major Bleeding With Transradial Access: Meta-analysis Michael O'Riordan August 29, 2022
News Conference News ESC 2018 MATRIX: 1-Year Results Confirm Superiority of Transradial PCI Michael O'Riordan August 25, 2018
News Opinion Editor's Corner ESC 2017 My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back Shelley Wood September 08, 2017
News Conference News ESC 2017 ESC Updates Guidelines for Treating STEMI Patients Michael O'Riordan August 27, 2017
News Conference News ESC 2017 Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART Shelley Wood August 27, 2017
Presentation ESC 2017 Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial Presenter: David Erlinge August 27, 2017
News Conference News ESC 2016 Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION Michael O'Riordan August 30, 2016
News Conference News ESC 2015 High-Sensitivity Troponin Assay Use Does Not Appear to Increase Diagnostic Procedures L.A. McKeown September 02, 2015
News Conference News ESC 2014 Post-Acute MI Survival Improving for Elderly Patients in France Todd Neale August 30, 2014
News Conference News ESC 2013 Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors Yael L. Maxwell September 04, 2013
News Conference News ESC 2013 Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients Caitlin E. Cox September 02, 2013
News Conference News ESC 2013 TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS Caitlin E. Cox September 01, 2013
News Conference News ESC 2012 Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis Caitlin E. Cox August 29, 2012
News Conference News Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS September 02, 2011